In 2023, the share of HIV-positive Tuberculosis patients on antiretroviral therapy (ART) in Indonesia is 22 units. This metric has shown a declining trend from 2013, starting at 47 units. Over the past two years (2022-2023), the share decreased by 4.3%. The Compound Annual Growth Rate (CAGR) over the last five years is -4.14%, reflecting a consistent downward trend. By 2028, it is forecasted to further decline to 17 units, indicating a 19.05% decrease from 2023.
Future trends to watch for:
- The impact of public health initiatives aimed at increasing ART coverage.
- Innovations in medical treatment and their adoption rates.
- Policy changes regarding HIV and Tuberculosis treatment protocols.
- Socio-economic factors influencing access to healthcare services.
